Arrowhead at an Inflexion - RNAi Momentum Meets Real Data
Arrowhead (ARWR) is trading near a new 52-week high after positive early obesity trial data and sustained technical strength. The market cap is roughly $11.1B while the pipeline (ARO-INHBE, ARO-ALK7 and multiple ARO candidates) gives multiple clinical and commercial paths. This trade idea lays out a risk-managed long with entry, stop and target and…